Global burden of tracheal, bronchus, and lung cancer attributable to second-hand smoke exposure from 1992 to 2021
An age-period-cohort analysis and 25-year mortality projections
Bibliographic Data
| ID | 22085588 |
|---|---|
| Authors | Hong-ming Lin, Hongming Lin (Fujian Medical University), Bin Lin (0000-0002-4099-309X, Fujian Medical University), Xin-peng Liao (Fujian Medical University), Hong Hong (0009-0001-4880-7765, Fujian Medical University), Xue-ting Cai (Fujian Medical University), Xi-bin Zhuang, Xibin Zhuang (0000-0001-7163-4236, Fujian Medical University, corresponding author) |
| Year | 2025 |
| Volume | 13 |
| Pages | 1625876-1625876 |
| Publication date | 2025-11-25 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2025.1625876 |
| PMID | 41377726 |
| OpenAlex | W4416676757 |
| Language | EN |
| References cited | 70 |
Background: Tracheal, bronchus, and lung (TBL) cancer remains the leading cause of cancer-related mortality worldwide. While smoking is the primary risk factor, several non-smoking-related factors also significantly contribute to TBL cancer, notably second-hand smoke (SHS) exposure, which plays a substantial role in the disease's burden. This study assesses and forecasts the temporal trends in the disease burden of TBL cancer attributable to SHS exposure at global, regional, and national levels. Methods: We extracted data from the ≥ 25 years population in the Global Burden of Disease Study 2021 (GBD 2021) to assess deaths, disability-adjusted life years (DALYs), age-standardized mortality rate (ASMR), and age-standardized DALY rate (ASDR) at both global and regional levels. We evaluated temporal trends using descriptive statistics, estimated annual percentage change (EAPC), and both the age-period-cohort (APC) and Bayesian age-period-cohort (BAPC) models. Results: From 1992 to 2021, absolute deaths and DALYs linked to TBL cancer due to SHS exposure increased, although ASMR and ASDR showed declining trends, with EAPC values of -0.92% and -1.30%, respectively. Regions with a high socio-demographic index (SDI) displayed the most significant improvements. In contrast, high-middle and middle SDI regions bore the greatest disease burden, and low SDI regions saw minimal progress. The highest ASMR in 2021 occurred mainly in Western Europe, North America, and East Asia, with ASMR correlating positively with SDI. The disease burden was consistently higher among males, particularly in the 65-74 age group, across both sexes. Future projections indicate a continuing decline in the disease burden from 2022 to 2046. Conclusion: SHS exposure continues to be a significant factor in the disease burden of TBL cancer. Although there has been an overall declining trend globally, it still caused the deaths of more than 97,000 people in 2021. There exists considerable heterogeneity among regions, with some areas still bearing a substantial disease burden. These findings highlight the need for specific prevention and control strategies to mitigate the health impacts of SHS exposure
Burden of disease · Disease · Disease burden · Lung cancer · Lung disease · Public health · Risk factor · Chronic Obstructive Pulmonary Disease (COPD) Research · Occupational and environmental lung diseases · Smoking Behavior and Cessation · Epidemiology
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Global cancer statistics 2022
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015
Projecting the future burden of cancer
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations
A Web Tool for Age–Period–Cohort Analysis of Cancer Incidence and Mortality Rates
Tobacco taxes as a tobacco control strategy
Worldwide burden of disease from exposure to second-hand smoke
Global burden of 87 risk factors in 204 countries and territories, 1990–2019
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017
Support for smoke-free policy, and awareness of tobacco health effects and use of smoking cessation therapy in a developing country
A descriptive model of the cigarette epidemic in developed countries
Tobacco control challenges in East Asia
Secondhand smoke exposure at home among one billion children in 21 countries
| Highly cited | No |
|---|